9781509558322 - Pharma Monopoly: The Battle for the Future of Medicines de Amin, Tahir; Malpani, Rohit (28 resultados)

Condición: New.

Condición: New.

Condición: As New. Unread book in perfect condition.

Hardback or Cased Book. Condición: New. Pharma Monopoly: The Battle for the Future of Medicines. Book.

Hardback. Condición: New. It is no secret that billions of people across the world lack the freedom and right to access life-saving medicines. For decades, people have fought to put this, though, as the Covid-19 pandemic made sickeningly clear, vast swaths of humanity are still left without. The reason: people are actively denied access to affordable medicines by outdated patent rules and economic policies dominated by neoliberalism. It is no accident, and it is not due to the pharmaceutical industry alone.Tahir Amin and Rohit Malpani, two leading figures in the access to medicines movement, examine the origins of this system of rules that champions monopolies and the false god of innovation over the public interest and human well-being. They tell the story of how, move by move, governments have ceded control to and then empowered pharmaceutical companies, making it increasingly hard to undo the damage wreaked along the way. From their unique vantage points and experiences, the authors critique global health initiatives and philanthropists for maintaining the status quo and warn of a future dominated by financial markets and artificial intelligence that will reinforce the worst practices of yesterday and portends new injustices for everyone.Ultimately, Pharma Monopoly questions the foundations of international efforts to improve access to medicines and calls for a new way forward that can rekindle a movement for justice.

Condición: New.

HRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.

Hardcover. Condición: new. Hardcover. It is no secret that billions of people across the world lack the freedom and right to access life-saving medicines. For decades, people have fought to put this, though, as the Covid-19 pandemic made sickeningly clear, vast swaths of humanity are still left without. The reason: people are actively denied access to affordable medicines by outdated patent rules and economic policies dominated by neoliberalism. It is no accident, and it is not due to the pharmaceutical industry alone.Tahir Amin and Rohit Malpani, two leading figures in the access to medicines movement, examine the origins of this system of rules that champions monopolies and the false god of innovation over the public interest and human well-being. They tell the story of how, move by move, governments have ceded control to and then empowered pharmaceutical companies, making it increasingly hard to undo the damage wreaked along the way. From their unique vantage points and experiences, the authors critique global health initiatives and philanthropists for maintaining the status quo and warn of a future dominated by financial markets and artificial intelligence that will reinforce the worst practices of yesterday and portends new injustices for everyone.Ultimately, Pharma Monopoly questions the foundations of international efforts to improve access to medicines and calls for a new way forward that can rekindle a movement for justice. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

hardcover. Condición: New.

Condición: new.

Condición: New.

Condición: New.

hardcover. Condición: New.

Condición: As New. Unread book in perfect condition.

Condición: New.

Hardcover. Condición: Brand New. 256 pages. 6.30x1.18x9.25 inches. In Stock.

Condición: New.

Hardback. Condición: New. New copy - Usually dispatched within 4 working days.

hardcover. Condición: New. Special order direct from the distributor.

Hardcover. Condición: Brand New. 256 pages. 6.30x1.18x9.25 inches. In Stock.

Condición: New. Brand new! Please provide a physical shipping address.

Hardcover. Condición: new. Hardcover. It is no secret that billions of people across the world lack the freedom and right to access life-saving medicines. For decades, people have fought to put this, though, as the Covid-19 pandemic made sickeningly clear, vast swaths of humanity are still left without. The reason: people are actively denied access to affordable medicines by outdated patent rules and economic policies dominated by neoliberalism. It is no accident, and it is not due to the pharmaceutical industry alone.Tahir Amin and Rohit Malpani, two leading figures in the access to medicines movement, examine the origins of this system of rules that champions monopolies and the false god of innovation over the public interest and human well-being. They tell the story of how, move by move, governments have ceded control to and then empowered pharmaceutical companies, making it increasingly hard to undo the damage wreaked along the way. From their unique vantage points and experiences, the authors critique global health initiatives and philanthropists for maintaining the status quo and warn of a future dominated by financial markets and artificial intelligence that will reinforce the worst practices of yesterday and portends new injustices for everyone.Ultimately, Pharma Monopoly questions the foundations of international efforts to improve access to medicines and calls for a new way forward that can rekindle a movement for justice. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

Condición: NEW.

Hardcover. Condición: new. Hardcover. It is no secret that billions of people across the world lack the freedom and right to access life-saving medicines. For decades, people have fought to put this, though, as the Covid-19 pandemic made sickeningly clear, vast swaths of humanity are still left without. The reason: people are actively denied access to affordable medicines by outdated patent rules and economic policies dominated by neoliberalism. It is no accident, and it is not due to the pharmaceutical industry alone.Tahir Amin and Rohit Malpani, two leading figures in the access to medicines movement, examine the origins of this system of rules that champions monopolies and the false god of innovation over the public interest and human well-being. They tell the story of how, move by move, governments have ceded control to and then empowered pharmaceutical companies, making it increasingly hard to undo the damage wreaked along the way. From their unique vantage points and experiences, the authors critique global health initiatives and philanthropists for maintaining the status quo and warn of a future dominated by financial markets and artificial intelligence that will reinforce the worst practices of yesterday and portends new injustices for everyone.Ultimately, Pharma Monopoly questions the foundations of international efforts to improve access to medicines and calls for a new way forward that can rekindle a movement for justice. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.

Condición: New.

Buch. Condición: Neu. Neuware - It is no secret that billions of people across the world lack the freedom and right to access life-saving medicines. For decades, people have fought to put this, though, as the Covid-19 pandemic made sickeningly clear, vast swaths of humanity are still left without. The reason: people are actively denied access to affordable medicines by outdated patent rules and economic policies dominated by neoliberalism. It is no accident, and it is not due to the pharmaceutical industry alone.Tahir Amin and Rohit Malpani, two leading figures in the access to medicines movement, examine the origins of this system of rules that champions monopolies and the false god of innovation over the public interest and human well-being. They tell the story of how, move by move, governments have ceded control to and then empowered pharmaceutical companies, making it increasingly hard to undo the damage wreaked along the way. From their unique vantage points and experiences, the authors critique global health initiatives and philanthropists for maintaining the status quo and warn of a future dominated by financial markets and artificial intelligence that will reinforce the worst practices of yesterday and portends new injustices for everyone.Ultimately, Pharma Monopoly questions the foundations of international efforts to improve access to medicines and calls for a new way forward that can rekindle a movement for justice.

Hardback. Condición: New. It is no secret that billions of people across the world lack the freedom and right to access life-saving medicines. For decades, people have fought to put this, though, as the Covid-19 pandemic made sickeningly clear, vast swaths of humanity are still left without. The reason: people are actively denied access to affordable medicines by outdated patent rules and economic policies dominated by neoliberalism. It is no accident, and it is not due to the pharmaceutical industry alone.Tahir Amin and Rohit Malpani, two leading figures in the access to medicines movement, examine the origins of this system of rules that champions monopolies and the false god of innovation over the public interest and human well-being. They tell the story of how, move by move, governments have ceded control to and then empowered pharmaceutical companies, making it increasingly hard to undo the damage wreaked along the way. From their unique vantage points and experiences, the authors critique global health initiatives and philanthropists for maintaining the status quo and warn of a future dominated by financial markets and artificial intelligence that will reinforce the worst practices of yesterday and portends new injustices for everyone.Ultimately, Pharma Monopoly questions the foundations of international efforts to improve access to medicines and calls for a new way forward that can rekindle a movement for justice.

Buch. Condición: Neu. Pharma Monopoly | The Battle for the Future of Medicines | Rohit Malpani (u. a.) | Buch | Einband - fest (Hardcover) | Englisch | 2026 | John Wiley and Sons Ltd | EAN 9781509558322 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu.